Advanced search
Publication Cover
Modern Rheumatology Volume 25, 2015 - Issue 1
Journal homepage
1,197
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Remarkable efficacy of tocilizumab for treating rheumatoid arthritis in patients with high platelet counts

Hiroaki MatsunoMatsuno Clinic for Rheumatic Diseases, Kureha-cho, Toyama city, Toyama, Japan, and Institute of Medical Science, Tokyo Medical University, Tokyo, JapanCorrespondence[email protected]
Pages 38-42 | Received 27 Jan 2014, Accepted 09 Apr 2014, Published online: 22 Dec 2014

References

  • Matsuno H. Treating of rheumatoid arthritis with biological agents. In: Matsuno H, ed. Innovative Rheumatology. Intech Co. 2013. p. 95–107.
  • Chiu Y, Ostor A, Hammond A, Sokoll K, Anderson M, Buch M, et al. Access to the wave of biological therapies for the treatment of arthritis in England and Wales. Clin Rheumatol. 2012;31(6):1005–12.
  • Matsuno H, Yudoh K, Katayama R, Nakazawa F, Uzuki M, Sawai T, et al.The role of TNF-α in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis: a study using a human RA/SCID mouse chimera. Rheumatology. 2002;41(3):329–37.
  • Emery P, Keystone E, Tony HP, Cantagrel A, Vollenhoven RV, Sanchez A, et al. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refactory to anti-tumor necrosis factor biologicals: results from a 24-weel multicenter randomized placebo-controlled trial. Ann Rheum Dis. 2008;67(11):1516–23.
  • Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hirano T, et al.Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood. 1989;74(4):1241–44.
  • Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of imflamation. Blood. 2003;102(3):783–8.
  • Katsume A, Saito H, Yamada Y, Yorozu K, Ueda O, Akamatsu K, et al.Anti-Interleukin6 (IL-6) receptor antibody suppresses Castleman's disease like symptoms emerged in IL-6 transgenic mice. Cytokine. 2002;20(6):304–11.
  • Zwerinca J, Redlich K, Polzer K, Joosten L, Krӧnke G, Distler J, et al.TNF-induced structural joint damage is mediated by IL-1. PNAS. 2007;104(28):11742–47.
  • Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthrithis. Arthritis Rheumatism. 1988;31(3):315–24.
  • Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham III CO, et al.Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580–8.
  • van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB. Effect of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet. 1989;1(8646):1036–8.
  • Wells G, Becker JC, Tang J, Dougado's M, Schiff M, Smolen H, et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009;68(6):954–60.
  • Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23(39):S100–8.
  • Matsuno H. Small molecule DMARD therapy and its position in RA treatment. In: Matsuno H, ed. Innovative Rheumatology. Intech Co. 2013. p. 165–87.
  • National Institute for Health and Clinical Excellence: NICE. http://www.nice.org.uk/nicemedia/live/13669/58202/58202.pdf.
  • Campbell K. Pathophysiology of anaemia. Nursing Times. 2004; 100(47):40–3.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.